What it means for nutraceutical ingredients and supply chains.
There is a quiet revolution happening beneath the surface of nutraceutical innovation, and it does not look like anything the industry has seen before. It does not begin in a field or follow a harvest season, nor does it rely on rainfall, soil conditions or geography. It begins in a fermentation tank, guided by science, and it is already reshaping how the industry thinks about where ingredients come from, how they are made, and what becomes possible when production is no longer bound by nature’s variability.
Fermentation itself is among the oldest biological processes ever harnessed, tied to everything from bread and cheese to traditional medicines and probiotics, but what is happening now goes far beyond that tradition. Advances in biotechnology have transformed fermentation into a precision production platform capable of manufacturing specific vitamins, amino acids, omega-3 fatty acids, postbiotics and other bioactive compounds with a level of consistency, purity and scalability that conventional agricultural sourcing cannot match.
The timing could not be more critical; climate volatility is disrupting crop yields and undermining the reliability of plant-based ingredient supply chains, while consumer demand for transparency in supplement production continues to rise. At the same time, regulatory scrutiny around ingredient quality and traceability is intensifying.
Geopolitical instability is further exposing the fragility of globally concentrated sourcing models, where disruptions in key agricultural regions can ripple across the industry with little warning. Meanwhile, the rise of plant-based and vegan formulations is accelerating demand for non-animal-derived alternatives, placing added pressure on conventional extraction methods that are increasingly unable to keep pace.
Sustainability expectations are no longer aspirational, as retailers, procurement teams and consumers now treat them as purchasing requirements, directly influencing which ingredients are selected and brought to market. Against this backdrop, the global supplement market continues to expand at a pace that traditional sourcing models cannot sustainably support, widening the gap between industry demand and what agriculture alone can reliably deliver each year.
Fermentation sits at the intersection of all of these pressures, and the brands and manufacturers that recognize its potential now will not only adapt more quickly, they will help define the next era of nutraceutical innovation.
From Traditional Process to Precision Platform
Fermentation has long played a role in nutraceuticals, primarily through the production of probiotics and fermented derivatives, an important foundation, but one with clear limitations. Today, that role is expanding into something far more advanced.
Modern fermentation operates at a fundamentally different level, with biomass fermentation remaining essential for probiotic strains and microbial proteins where the microorganism itself serves as the active ingredient. At the same time, continued advances in strain selection, stabilization and encapsulation have significantly improved viability and shelf stability across applications such as gut health, immunity and metabolic wellness.
More transformative, however, is the rise of precision fermentation. Through metabolic engineering and synthetic biology, microorganisms can now be programmed to produce specific molecules including vitamins, enzymes, peptides, fatty acids and other bioactives with high specificity and yield. This effectively decouples ingredient production from its traditional source, enabling consistent, controlled manufacturing independent of geography, seasonality or agricultural variability.
Across key ingredient categories, this shift is already taking shape; CoQ10 can now be produced with the consistency required for clinical-grade applications, reducing the variability that has historically affected purity, while omega-3 fatty acids, long dependent on fish oil with its supply chain fragility and sustainability concerns are increasingly produced through algal fermentation, offering a marine-free, traceable and scalable alternative.3,4 Beyond replication, fermentation can be fine-tuned to influence the structure and functionality of compounds, enabling enhanced bioavailability and targeted biological activity that conventional extraction methods cannot achieve.
Sustainability That Goes Beyond the Label
Sustainability in ingredient sourcing is often discussed in aspirational terms, but fermentation offers something more concrete, production that happens in bioreactors rather than open fields, requiring a fraction of the land and water needed for equivalent agricultural output. When the full picture is considered, including processing, transportation and supply chain complexity, the environmental footprint of fermentation-based production is frequently lower than conventional methods, especially for ingredients that require extensive downstream processing.
Fermentation systems can also run on plant-derived sugars and, increasingly, on agricultural byproducts and waste streams, creating circular production models that turn what would otherwise be discarded into valuable inputs. Production can be localized, shortening transport distances and building supply chain resilience in ways that geographically dispersed agricultural sourcing cannot replicate.
Energy consumption at commercial scale remains a real consideration and should be acknowledged transparently, as large fermentation facilities carry an energy footprint that requires active management, while advances in process optimization and the integration of renewable energy sources continue to close that gap.
As sustainability becomes increasingly embedded in procurement decisions, these advantages translate into tangible commercial impact.
An Expanding Ingredient Landscape
The global precision fermentation market is projected to grow from approximately $5.8 billion in 2025 to more than $151 billion by 2034, reflecting real commercial momentum rather than early-stage research interest.9 What was once largely confined to research and niche applications is now being deployed at scale, reshaping how key nutrients and bioactives are produced across the supplement industry. Fermentation is no longer an emerging capability; it is an established production platform supporting a growing number of commercially viable ingredients.
In the supplement space, fermentation has become the dominant production method for several key nutrients, including vitamin B12, which offers a non-animal-derived alternative critical to plant-based formulation, and MK-7, which delivers the all-trans configuration associated with optimal biological activity at purity levels that natto extraction cannot reliably match.1,2
Among the most significant recent developments is the FDA’s (U.S. Food and Drug Administration) September 2025 confirmation that NMN is lawful for use in dietary supplements, reversing a 2022 decision that had effectively removed it from the market. NMN is a direct precursor to NAD, a coenzyme central to cellular energy, DNA repair and metabolic function, and it can now be produced via precision fermentation at purity levels exceeding 98 percent, a standard that traditional extraction cannot consistently achieve. The ability to combine NMN with NAD in a single formulation represents a real advance for the healthy aging and longevity categories, and one that has become commercially viable through fermentation.8
The antioxidant category is also being reshaped, with astaxanthin, one of the most potent antioxidants available in supplement formulation, having traditionally been sourced from microalgae, with limitations that include high lipid content that dilutes potency, batch-to-batch variability, and a fishy taste and odor that complicate formulation in consumer-facing formats. Yeast-based fermentation is now addressing these constraints, producing astaxanthin with significantly higher concentrations of free-form active, in the same isomeric form found in wild Atlantic salmon, without the associated sensory challenges, and with a markedly cleaner profile.8
Amino acids further illustrate this evolution, with fermentation now serving as the production method of choice. Essential amino acids including leucine, lysine and threonine, which are foundational to sports nutrition and recovery formulations, can be produced with a level of efficiency and consistency that agricultural sourcing cannot match. Beyond the basics, attention is growing around functional peptides with specific physiological benefits, compounds that are not available at commercial scale through traditional production methods.
Postbiotics represent one of the most promising areas of development. Unlike probiotics, which require live microorganisms that are notoriously difficult to keep viable through processing, storage, and shelf life, postbiotics are the bioactive compounds produced during fermentation, including short-chain fatty acids, bacteriocins and enzyme fractions that support gut health, immune function, and inflammation management without the stability challenges associated with live cultures.6,7 Because they are inherently stable, they can be incorporated into a far wider range of delivery formats, from gummies and powders to ready-to-drink products, opening applications that live probiotics cannot easily support.
Beyond these established categories, fermentation is opening access to compounds that were previously out of reach at commercial scale: adaptogenic actives, rare antioxidants and bioidentical molecules that exist in nature but cannot be reliably or sustainably extracted from their natural sources.
Quality and Consistency Where It Counts
Ingredient variability remains one of the most persistent challenges in formulation. When the same botanical extract delivers different active compound levels from one harvest to the next, everything downstream is affected, including dosing accuracy, formulation stability, clinical validation and ultimately the consumer experience. Weather, soil conditions and harvest timing are outside anyone’s control, and managing that variability through processing adds cost and complexity without ever fully resolving the issue.
Fermentation removes most of that uncertainty, as temperature, pH, oxygen levels, and nutrient availability are precisely controlled in a bioreactor, resulting in highly reproducible output from one batch to the next. For brands making specific dosing claims or building products around clinical evidence, that consistency is not a minor operational benefit; it is what makes those claims defensible and that evidence meaningful.
An additional advantage lies in reduced exposure to contaminants. Fermentation-derived ingredients are not subject to the pesticides, heavy metals and environmental pollutants that can enter agricultural supply chains, simplifying quality assurance at a time when regulatory scrutiny over raw material purity and traceability continues to increase.
Where Fermentation Meets Formulation
The full value of fermentation is realized not at the ingredient level, but in the finished product—nowhere more evident than in solubility. Many high-value actives remain difficult to formulate in liquid formats due to poor solubility. Fermentation-derived CoQ10, produced in a water-dispersible form, enables applications in beverages, effervescent formats and ready-to-drink supplements that conventional oil-based CoQ10 cannot support, unlocking entirely new product categories rather than incremental improvements.
Certain actives are inherently bitter, astringent or present undesirable taste profiles that require masking across gummies, soft chews, powders and drinkable formats. When a fermentation-derived ingredient integrates more cleanly, it reduces flavor system complexity and delivers a more natural-tasting product, ultimately improving adherence and repeat use.
Bioavailability may be the most strategically significant advantage. Fermented curcumin, for example, has demonstrated improved absorption compared to standard extracts, not because the molecule itself changes, but because the fermentation process alters its physical form and behavior in the body.5 This is where fermentation extends beyond sourcing, with upstream production decisions shaping downstream clinical performance.
These advantages still require careful formulation work, as fermented ingredients must be evaluated alongside co-actives, excipients, sweeteners and pH-modifying agents, all of which interact in ways that affect stability, compatibility and how the active is ultimately released. The opportunity is real, but it is realized through rigorous development, not assumption.
Navigating Regulatory and Consumer Expectations
Regulatory strategy and fermentation strategy cannot be planned separately, and brands that treat them as independent considerations often encounter challenges later in development.
In the United States, many fermentation-derived ingredients qualify as GRAS (generally recognized as safe) or are supported by existing safety dossiers, making the path to market relatively straightforward for established compounds.10 However, precision fermentation using genetically engineered microorganisms may require additional documentation and, in some markets, pre-market approval, adding time and cost to development and reinforcing the need to integrate regulatory considerations from the outset.11
Consumer perception remains favorable toward fermentation, supported by strong associations with naturalness, tradition and gut health. Where precision fermentation involves genetic engineering, that goodwill requires active management, as the distinction between fermentation-derived and genetically modified ingredients is not always clear. Brands that build lasting trust will be those that communicate their production methods clearly and transparently.
The Role of CDMOs in Bringing it all Together
Understanding the potential of a fermentation-derived ingredient is one challenge; translating it into a finished product that performs consistently at commercial scale is another, and the gap between the two is where many brands underestimate what is involved.
Bringing fermentation innovation to market requires expertise in microbial systems, ingredient characterization, process scaling and the formulation work that determines whether a fermented active delivers in a real product, not just in a controlled setting. For most brands, building that capability internally is neither practical nor the best use of resources, particularly as the technology continues to evolve.
CDMOs that have invested in fermentation expertise and manufacturing capability are increasingly stepping into this gap, helping brands evaluate which fermented ingredients are appropriate for specific formats, optimize delivery systems around their functional properties, and ensure that quality and sustainability claims hold up under scrutiny. The relationship between fermentation science and contract manufacturing is becoming one of the most strategically important in the industry, with CDMOs playing a central role in navigating a production landscape that remains new territory for many brands.
Looking Forward
Fermentation is not a trend the industry is moving toward; it is infrastructure the industry is building on, and the pace of that development continues to accelerate.
As precision fermentation matures, brands will gain access to an expanding range of bioactives designed for specific health outcomes, produced under controlled conditions, validated with clinical data, and delivered in formats optimized for the consumer experience. The ingredients of the next decade may not come from fields or extraction facilities, but from fermentation systems designed to produce them with precision and intent.
For an industry facing increasing complexity around supply chain reliability, ingredient quality and consumer trust, fermentation offers something increasingly rare: a production model that becomes more capable, consistent and strategically valuable as these demands grow. NIE
References:
1 Gnosis by Lesaffre. Vitamin K2: From a Natural Fermentation Process or From Synthesis. https://gnosisbylesaffre.com/blog/vitamin-k2-natural-origin-or-synthetic/.
2 Ren L, Peng C, Hu X, Han Y, Huang H. Microbial production of vitamin K2: current status and future prospects. Biotechnology Advances. 2020;39:107453. https://pmc.ncbi.nlm.nih.gov/articles/PMC8954062/.
3 Arterburn LM et al. Comparative Bioavailability of DHA and EPA from Microalgal and Fish Oil in Adults. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC12524788/.
4 Wen ZY, Chen F. Omega-3 Biotechnology: A Green and Sustainable Process for Omega-3 Fatty Acids Production. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC4600955/.
5 Villarreal-Soto SA et al. Fermentation enhances curcumin’s solubility and bioavailability. Frontiers in Nutrition. 2025. www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2025.1625816/full.
6 Zółkiewicz J et al. Postbiotics and Their Health Modulatory Biomolecules. PMC. 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9688025/.
7 International Scientific Association for Probiotics and Prebiotics (ISAPP). Consensus Statement on the Definition of Postbiotics. 2021. www.isapp.net.
8 Nutraceuticals World. Precision Fermentation: Manufacturing Pure Ingredients Sustainably. 2025. www.nutraceuticalsworld.com/exclusives/precision-fermentation-manufacturing-pure-ingredients-sustainably/.
9 Straits Research. Precision Fermentation Market Size, Share and Demand Trends to 2034. 2025. https://straitsresearch.com/report/precision-fermentation-market.
10 U.S. Food and Drug Administration. Generally Recognized as Safe (GRAS). www.fda.gov/food/food-ingredients-packaging/generally-recognized-safe-gras; U.S. FDA. Regulatory Framework for Substances Intended for Use in Human Food or Animal Food on the Basis of the GRAS Provision of the FD&C Act. November 2017. www.fda.gov/food/guidance-documents-regulatory-information-topic-food-and-dietary-supplements/ingredients-additives-gras-packaging-guidance-documents-regulatory-information.
11 SGS USA. Choosing the Right US Regulatory Pathway for Your Food and Dietary Supplement Ingredients: GRAS and NDIN. July 2024. www.sgs.com/en-us/news/2024/07/choosing-the-right-us-regulatory-pathway-for-your-food-and-dietary-supplement-ingredients.
12 Lester H et al. Precision Fermentation: Navigating the Legalities. FI Global Insights. November 2025. https://insights.figlobal.com/regulations/precision-fermentation-navigating-the-legalities.
Evelyn Reinson is director of Brand & Consumer Engagement at Sirio Pharma, a leading global nutraceutical contract development and manufacturing organization (CDMO) with extensive expertise in an array of delivery formats, including gummies, soft gels, capsules, tablets, powders, functional beverages, probiotics and other innovative dosage forms. Sirio operates multiple manufacturing sites across the United States, Germany and China. www.siriopharma.com.
